Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 255 K137 K218 K324 K229 K 908 K Research & development ————— — Operating income 11.36 M6.7 M5.58 M-11.29 M11.61 M 12.6 M Non-Operating Income, Total 159 K155 K275 K227 K251 K 908 K Interest expense, net of interest capitalized 8.14 M8.48 M8.32 M7.9 M7.18 M 31.87 M Non-Operating Income, excl. Interest Expenses -7.98 M-8.32 M-8.04 M-7.67 M-6.92 M -30.96 M Unusual income/expense ————— — Pretax income 3.72 M38 K672 K-8.52 M2.94 M -4.87 M Equity in earnings ————— — Taxes 744 K7 00046 K-2.96 M530 K -2.37 M Non-controlling/minority interest 0000— — After tax other income/expense ————— — Net income before discontinued operations 2.97 M31 K626 K-5.56 M2.41 M -2.49 M Discontinued operations ————— — Net income 2.97 M31 K626 K-5.56 M2.41 M -2.49 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 2.91 M31 K614 K-1.66 M2.37 M 1.35 M Basic earnings per share (Basic EPS) 0.4800.1-0.890.38 -0.41 Diluted earnings per share (Diluted EPS) 0.410.060.1-0.880.38 -0.34 Average basic shares outstanding 4 7494 7594 7694 8314 838 — Diluted shares outstanding 4 7494 8154 8214 7774 885 — EBITDA 4 M-1 M-1.53 M-18.25 M4.98 M -15.8 M EBIT 3.33 M-1.67 M-2.56 M-19.08 M4.45 M -18.85 M Cost of revenue 457 K1.2 M3.49 M11.19 M-168 K 15.72 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 667 K664 K1.03 M828 K531 K 3.05 M